What are the management and treatment options for a patient presenting with seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Seizure Management and Treatment: Prescription Templates by Seizure Type

Status Epilepticus (Active Seizure ≥5 minutes)

For any patient actively seizing, immediately administer IV lorazepam 4 mg at 2 mg/min as first-line treatment, followed by fosphenytoin or valproate as second-line if seizures persist. 1, 2, 3

First-Line Treatment (0-5 minutes)

  • Lorazepam 4 mg IV at 2 mg/min (preferred benzodiazepine due to longer duration of action) 1, 2, 3
  • Alternative if no IV access: Midazolam 10 mg IM or intranasal 1, 4
  • Check fingerstick glucose immediately and correct hypoglycemia 5
  • Establish IV access, monitor vital signs, ensure airway equipment available 3

Prescription Template - Status Epilepticus First-Line:

Lorazepam 4 mg IV push at 2 mg/min
May repeat once after 10-15 minutes if seizures continue
Maximum total dose: 8 mg

Second-Line Treatment (5-20 minutes if seizures persist)

Choose ONE of the following agents 1, 2, 5:

Option 1: Fosphenytoin (most widely available, 95% of neurologists' choice)

  • Dose: 20 mg PE/kg IV at maximum rate 150 mg PE/min 1, 2, 5
  • Efficacy: 84% 2, 5
  • Risk: 12% hypotension, requires continuous ECG and BP monitoring 2, 5

Prescription Template - Fosphenytoin:

Fosphenytoin 20 mg PE/kg IV (max rate 150 mg PE/min)
For 70 kg patient: 1400 mg PE IV over 10 minutes
Continuous cardiac monitoring required
Monitor BP every 5 minutes during infusion

Option 2: Valproate (preferred if hypotension concern)

  • Dose: 30 mg/kg IV over 5-20 minutes 1, 2, 5
  • Efficacy: 88% 2, 5
  • Risk: 0% hypotension (superior safety profile) 2, 5

Prescription Template - Valproate:

Valproate 30 mg/kg IV over 10 minutes
For 70 kg patient: 2100 mg IV over 10 minutes
Infusion rate: 6 mg/kg/hour
Monitor liver function

Option 3: Levetiracetam (minimal cardiovascular effects)

  • Dose: 30 mg/kg IV over 5 minutes 2, 5
  • Efficacy: 68-73% 2, 5
  • Advantage: Minimal adverse effects, no hypotension 5

Prescription Template - Levetiracetam:

Levetiracetam 30 mg/kg IV over 5 minutes
For 70 kg patient: 2100 mg IV over 5 minutes
Infusion rate: 5 mg/kg/min
No cardiac monitoring required

Option 4: Phenobarbital

  • Dose: 20 mg/kg IV at 50-100 mg/min 2, 5
  • Efficacy: 58% 2, 5
  • Risk: Higher respiratory depression 2

Prescription Template - Phenobarbital:

Phenobarbital 20 mg/kg IV over 10 minutes
For 70 kg patient: 1400 mg IV over 10 minutes
Prepare for respiratory support
Monitor respiratory rate continuously

Refractory Status Epilepticus (Seizures continue after benzodiazepine + one second-line agent)

Initiate continuous EEG monitoring and choose ONE anesthetic agent 2, 5:

Option 1: Midazolam Infusion (first choice - 80% efficacy, 30% hypotension)

  • Loading: 0.15-0.20 mg/kg IV 2, 5
  • Infusion: 1 mg/kg/min, titrate up by 1 mg/kg/min every 15 minutes to max 5 mg/kg/min 2, 5

Prescription Template - Midazolam Infusion:

Midazolam 0.2 mg/kg IV bolus (14 mg for 70 kg patient)
Then continuous infusion starting at 1 mg/kg/min (70 mg/hour for 70 kg patient)
Titrate up by 1 mg/kg/min every 15 minutes as needed
Maximum rate: 5 mg/kg/min (350 mg/hour for 70 kg patient)
Requires mechanical ventilation
Continuous EEG monitoring
Load maintenance AED (phenytoin/valproate/levetiracetam) during infusion

Option 2: Propofol (73% efficacy, requires mechanical ventilation)

  • Loading: 2 mg/kg IV bolus 2, 5
  • Infusion: 3-7 mg/kg/hour 2, 5
  • Advantage: Shorter ventilation time (4 days vs 14 days with pentobarbital) 5

Prescription Template - Propofol:

Propofol 2 mg/kg IV bolus (140 mg for 70 kg patient)
Then continuous infusion 3-7 mg/kg/hour (210-490 mg/hour for 70 kg patient)
Requires mechanical ventilation
Continuous BP monitoring (42% hypotension risk)
Continuous EEG monitoring to guide titration

Option 3: Pentobarbital (highest efficacy 92%, highest hypotension 77%)

  • Loading: 13 mg/kg IV 2, 5
  • Infusion: 2-3 mg/kg/hour 2, 5

Prescription Template - Pentobarbital:

Pentobarbital 13 mg/kg IV bolus (910 mg for 70 kg patient)
Then continuous infusion 2-3 mg/kg/hour (140-210 mg/hour for 70 kg patient)
Requires mechanical ventilation
Aggressive BP support (77% hypotension risk)
Continuous EEG monitoring
Expect prolonged ventilation (14 days average)

First Unprovoked Seizure (Patient returned to baseline)

Do not initiate antiepileptic medication in the ED for patients with a first unprovoked seizure without evidence of brain disease or injury. 1

Decision Algorithm for First Seizure

DO NOT treat in ED if: 1

  • Single unprovoked seizure
  • No history of CNS injury (stroke, trauma, tumor)
  • Patient returned to neurologic baseline
  • Outpatient neurology follow-up arranged

Prescription Template - First Unprovoked Seizure (No Treatment):

No antiepileptic medication initiated
Discharge with neurology follow-up within 1-2 weeks
Seizure precautions counseling
Driving restrictions per state law
Return precautions for seizure recurrence

MAY initiate treatment if: 1

  • Remote history of brain disease or injury (stroke, TBI, tumor)
  • Abnormal EEG findings
  • Abnormal neuroimaging
  • Coordinate with neurology for outpatient initiation

Prescription Template - First Seizure with Risk Factors:

Option 1: Defer to outpatient neurology (preferred)
Option 2: If initiating in ED after neurology consultation:
  Levetiracetam 500 mg PO twice daily
  OR
  Lamotrigine 25 mg PO daily x 2 weeks, then 50 mg daily
  Neurology follow-up within 1 week

DO NOT admit to hospital: 1

  • Patients with first unprovoked seizure who returned to baseline
  • No evidence supporting admission reduces 24-hour adverse events 1

Provoked Seizure (Acute Symptomatic Seizure)

Do not initiate antiepileptic medication in the ED for provoked seizures - identify and treat the underlying cause instead. 1, 5

Common Precipitating Causes to Address 1, 5:

  • Hypoglycemia - correct with dextrose
  • Hyponatremia - correct sodium cautiously
  • Hypoxia - supplemental oxygen, treat underlying cause
  • Drug toxicity - supportive care, specific antidotes
  • Alcohol/drug withdrawal - benzodiazepines, supportive care
  • CNS infection - antibiotics, antivirals
  • Stroke/hemorrhage - neurosurgical consultation
  • Metabolic derangements - correct underlying abnormality

Prescription Template - Provoked Seizure:

No antiepileptic medication for seizure prevention
Treat underlying cause:
  - If hypoglycemia: Dextrose 50% 50 mL IV
  - If hyponatremia: 3% saline per protocol
  - If alcohol withdrawal: Lorazepam 2 mg IV q15min PRN CIWA >10
  - If CNS infection: Appropriate antimicrobials
Admit for treatment of underlying condition

Known Epilepsy with Breakthrough Seizure (Subtherapeutic Levels)

If Patient Takes Phenytoin/Fosphenytoin

Prescription Template - Phenytoin Reloading:

Check current phenytoin level
Calculate loading dose to achieve level 20 mcg/mL:
  Loading dose (mg) = (20 - current level) × 0.7 × weight (kg)
Administer fosphenytoin IV at max rate 150 mg PE/min
Resume home phenytoin dose
Ensure medication compliance counseling
Outpatient neurology follow-up

If Patient Takes Other AEDs

Prescription Template - Resume Home AED:

Administer one dose of home AED in ED:
  - If oral AED: Give home dose PO
  - If available IV formulation: Give IV equivalent
Ensure patient has adequate supply at home
Medication compliance counseling
Social work consult if financial barriers
Outpatient neurology follow-up within 1 week

Focal Seizures (Outpatient Initiation)

For newly diagnosed focal epilepsy requiring outpatient treatment initiation 6, 7:

Prescription Template - Focal Seizures (Adults):

First-line options (choose ONE):
1. Levetiracetam 500 mg PO twice daily
   Titrate by 500 mg/day every 1-2 weeks
   Target: 1000-1500 mg twice daily
   
2. Lamotrigine 25 mg PO daily x 2 weeks
   Then 50 mg daily x 2 weeks
   Then 100 mg daily x 1 week
   Target: 100-200 mg twice daily
   (Slower titration reduces rash risk)
   
3. Carbamazepine 200 mg PO twice daily
   Titrate by 200 mg/day every week
   Target: 400-600 mg twice daily
   Check CBC, LFTs at baseline

Neurology follow-up in 2-4 weeks
Seizure diary
Driving restrictions per state law

Prescription Template - Focal Seizures (Elderly):

Preferred: Lamotrigine or Gabapentin (better tolerated)

Lamotrigine 25 mg PO daily x 2 weeks
Then 25 mg twice daily x 2 weeks
Then 50 mg twice daily
Target: 50-100 mg twice daily (lower than adults)

OR

Gabapentin 300 mg PO at bedtime x 3 days
Then 300 mg twice daily x 4 days
Then 300 mg three times daily
Target: 300-600 mg three times daily

Neurology follow-up in 2 weeks
Fall precautions

Generalized Seizures (Outpatient Initiation)

Prescription Template - Generalized Seizures (Not Women of Childbearing Age):

Valproate 250 mg PO twice daily
Titrate by 250 mg/day every 3-7 days
Target: 500-1000 mg twice daily
Check LFTs, CBC, ammonia at baseline
Neurology follow-up in 2-4 weeks

Prescription Template - Generalized Seizures (Women of Childbearing Age):

AVOID valproate due to teratogenicity

Preferred: Levetiracetam 500 mg PO twice daily
Titrate by 500 mg/day every 1-2 weeks
Target: 1000-1500 mg twice daily

OR

Lamotrigine 25 mg PO daily x 2 weeks
Then 50 mg daily x 2 weeks
Then 100 mg daily x 1 week
Target: 100-200 mg twice daily

Contraception counseling
Folic acid 1-4 mg daily if pregnancy possible
Neurology follow-up in 2-4 weeks

Critical Pitfalls to Avoid

  • Never use neuromuscular blockers alone - they mask motor manifestations while electrical seizure activity continues causing brain injury 5
  • Never skip directly to third-line agents without trying benzodiazepines and a second-line agent 5
  • Never delay benzodiazepines - lorazepam has 65% efficacy as monotherapy for status epilepticus 2, 3
  • Always search for reversible causes simultaneously with treatment initiation 1, 5
  • Monitor for hypotension with phenytoin/fosphenytoin (12% risk) and pentobarbital (77% risk) 2, 5
  • Prepare for mechanical ventilation before administering propofol or high-dose midazolam 5, 3
  • Load maintenance AED during midazolam infusion to ensure adequate levels before tapering 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Status Epilepticus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Emergent Management of Status Epilepticus.

Continuum (Minneapolis, Minn.), 2024

Guideline

Status Epilepticus Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Adult Onset Seizures.

Mayo Clinic proceedings, 2017

Research

Treating epilepsy across its different stages.

Therapeutic advances in neurological disorders, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.